DOO opened at C$50.82 on Thursday. The company has a debt-to-equity ratio of 573.79, a quick ratio of 0.20 and a current ratio of 1.37. BRP has a 1-year low of C$50.67 and a 1-year high of C$102. ...

In a report released today, Ingrid Rico from Stifel Nicolaus maintained a Buy rating on Integra Resources Corp (ITR – Research Report), with a price target of C$4.00. The company’s shares ...

Knight Therapeutics (TSE:GUD – Get Free Report) had its target price boosted by Stifel Nicolaus from C$6.25 to C$7.45 in a research report issued to clients and investors on Tuesday,BayStreet.CA ...

NASDAQ:BLNK opened at $0.94 on Wednesday. The company’s fifty day moving average price is $1.10 and its 200-day moving average price is $1.51. Blink Charging has a 1-year low of $0.87 and a 1 ...

Analysts at Stifel Nicolaus began coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a report released on Tuesday, MarketBeat Ratings reports. The firm set a ...

In a report released today, Matthew Smith, CFA from Stifel Nicolaus maintained a Hold rating on McCormick & Company (MKC – Research Report), with a price target of $82.00. The company’s shares ...

In a report released today, Benjamin Nolan from Stifel Nicolaus maintained a Buy rating on New Fortress Energy (NFE – Research Report), with a price target of $16.00. The company’s shares ...

In a report released on March 21, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with a price target of $10.00. The company’s shares ...

Stifel Nicolaus analyst Stephen Willey maintained a Hold rating on MacroGenics (MGNX – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $2.10.

Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe to Barron's, click here. If you're a wealth managment professional and ...

Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe to Barron's, click here. If you're a wealth managment professional and ...

Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The company’s shares closed yesterday at $36.45.